TABLE 1.
Organism (nb) and antimicrobial agent | MIC50 | MIC90 | Geometric mean MIC | Range | %S | %I | %R |
---|---|---|---|---|---|---|---|
B. fragilis (81) | |||||||
Doripenem (116)c | 0.5 | 1 | 0.5 | 0.25-16 | 96 | 3 | 1 |
Ertapenem | 0.25 | 0.5 | 0.3 | 0.12-4 | 100 | 0 | 0 |
Imipenem | 0.25 | 0.5 | 0.2 | 0.06-2 | 100 | 0 | 0 |
Meropenem | 0.12 | 0.5 | 0.2 | 0.12-8 | 97 | 3 | 0 |
Ceftriaxone | 32 | >32 | 25.7 | 8->32 | 15 | 48 | 37 |
Levofloxacin | 2 | 2 | 1.5 | 0.50-8 | 91 | 5 | 4 |
B. ovatus (20) | |||||||
Doripenem (27) | 0.5 | 1 | 0.4 | 0.12-2 | 100 | 0 | 0 |
Ertapenem | 0.5 | 1 | 0.5 | 0.12-2 | 100 | 0 | 0 |
Imipenem | 0.25 | 0.5 | 0.2 | 0.06-0.50 | 100 | 0 | 0 |
Meropenem | 0.25 | 0.5 | 0.2 | 0.03-0.50 | 100 | 0 | 0 |
Ceftriaxone | 32 | >32 | 25 | 8->32 | 20 | 50 | 30 |
Levofloxacin | 8 | 16 | 7.5 | 4-16 | 0 | 25 | 75 |
B. thetaiotaomicron (42) | |||||||
Doripenem (44) | 0.5 | 1 | 0.6 | 0.12-2 | 100 | 0 | 0 |
Ertapenem | 0.5 | 2 | 0.6 | 0.06-2 | 100 | 0 | 0 |
Imipenem | 0.5 | 1 | 0.4 | 0.03-1 | 100 | 0 | 0 |
Meropenem | 0.25 | 0.5 | 0.3 | 0.06-1 | 100 | 0 | 0 |
Ceftriaxone | 32 | >32 | 31.1 | 16->32 | 2 | 58 | 40 |
Levofloxacin | 8 | 8 | 6.3 | 1->32 | 2 | 29 | 69 |
Other B. fragilis grp. species (23) | |||||||
Doripenem (39) | 0.5 | 2 | 0.6 | 0.12-16 | 98 | 0 | 2 |
Ertapenem | 0.5 | 2 | 0.6 | 0.12-2 | 100 | 0 | 0 |
Imipenem | 0.5 | 1 | 0.4 | 0.03-1 | 100 | 0 | 0 |
Meropenem | 0.25 | 0.5 | 0.3 | 0.06-1 | 100 | 0 | 0 |
Ceftriaxone | 32 | >32 | 30.3 | 16->32 | 4 | 53 | 43 |
Levofloxacin | 2 | 16 | 3.9 | 1-32 | 52 | 13 | 35 |
Bilophila wadsworthia (21) | |||||||
Doripenem | 0.12 | 0.12 | 0.1 | 0.03-0.12 | 100 | 0 | 0 |
Ertapenem | 0.12 | 0.12 | 0.1 | 0.03-0.12 | 100 | 0 | 0 |
Imipenem | 0.12 | 0.25 | 0.1 | 0.06-0.25 | 100 | 0 | 0 |
Meropenem | 0.062 | 0.12 | 0.1 | 0.03-0.12 | 100 | 0 | 0 |
Ceftriaxone | >32 | >32 | 13.4 | 0.03->32 | 10 | 47 | 43 |
Levofloxacin | 1 | 4 | 1.1 | 0.25-16 | 86 | 9 | 5 |
Fusobacterium species (15) | |||||||
Doripenem | 0.031 | 1 | 0.1 | 0.03-1 | 100 | 0 | 0 |
Ertapenem | 0.031 | 1 | 0 | 0.03->32 | 93 | 0 | 7 |
Imipenem | 0.12 | 1 | 0.1 | 0.03-2 | 100 | 0 | 0 |
Meropenem | 0.031 | 0.12 | 0 | 0.03-0.50 | 100 | 0 | 0 |
Ceftriaxone | 0.5 | 32 | 0.6 | 0.06->32 | 87 | 6 | 7 |
Levofloxacin | 1 | 1 | 0.8 | 0.25-1 | 100 | 0 | 0 |
Porphyromonas species (20) | |||||||
Doripenem | 0.031 | 0.5 | 0.1 | 0.03-4 | 100 | 0 | 0 |
Ertapenem | 0.031 | 0.5 | 0.1 | 0.03-32 | 95 | 0 | 5 |
Imipenem | 0.031 | 0.12 | 0.1 | 0.03-1 | 100 | 0 | 0 |
Meropenem | 0.031 | 0.5 | 0.1 | 0.03-8 | 95 | 5 | 0 |
Ceftriaxone | 0.12 | 1 | 0.2 | 0.03->32 | 95 | 0 | 5 |
Levofloxacin | 0.25 | 1 | 0.4 | 0.06-2 | 100 | 0 | 0 |
Prevotella oris/buccae (10) | |||||||
Doripenem | 0.12 | 0.5 | 0.2 | 0.03-0.50 | 100 | 0 | 0 |
Ertapenem | 0.12 | 0.25 | 0.2 | 0.06-0.50 | 100 | 0 | 0 |
Imipenem | 0.062 | 0.25 | 0.1 | 0.03-0.50 | 100 | 0 | 0 |
Meropenem | 0.12 | 0.25 | 0.1 | 0.03-0.25 | 100 | 0 | 0 |
Ceftriaxone | 8 | >32 | 3.3 | 0.50->32 | 50 | 20 | 30 |
Levofloxacin | 1 | 1 | 1.1 | 0.50-4 | 90 | 10 | 0 |
Prevotella bivia and disiens (15) | |||||||
Doripenem | 0.12 | 0.5 | 0.1 | 0.03-4 | 100 | 0 | 0 |
Ertapenem | 0.25 | 0.5 | 0.2 | 0.03-1 | 100 | 0 | 0 |
Imipenem | 0.062 | 0.25 | 0.1 | 0.03-2 | 100 | 0 | 0 |
Meropenem | 0.12 | 0.5 | 0.1 | 0.03-2 | 100 | 0 | 0 |
Ceftriaxone | 2 | 32 | 1.9 | 0.12->32 | 87 | 6 | 7 |
Levofloxacin | 1 | 8 | 1.4 | 0.25-8 | 73 | 7 | 20 |
Prevotella intermedia/nigrescens (10) | |||||||
Doripenem | 0.031 | 0.062 | 0 | 0.03-0.06 | 100 | 0 | 0 |
Ertapenem | 0.031 | 0.062 | 0 | 0.03-0.06 | 100 | 0 | 0 |
Imipenem | 0.031 | 0.031 | 0 | 0.03-0.03 | 100 | 0 | 0 |
Meropenem | 0.062 | 0.062 | 0.1 | 0.03-0.06 | 100 | 0 | 0 |
Ceftriaxone | 0.12 | 4 | 0.3 | 0.03-8 | 100 | 0 | 0 |
Levofloxacin | 0.5 | 0.5 | 0.5 | 0.50-0.50 | 100 | 0 | 0 |
Other Prevotella species (22) | |||||||
Doripenem | 0.062 | 0.12 | 0.1 | 0.03-0.25 | 100 | 0 | 0 |
Ertapenem | 0.062 | 0.25 | 0.1 | 0.03-0.25 | 100 | 0 | 0 |
Imipenem | 0.031 | 0.062 | 0 | 0.03-0.12 | 100 | 0 | 0 |
Meropenem | 0.062 | 0.25 | 0.1 | 0.03-0.25 | 100 | 0 | 0 |
Ceftriaxone | 0.25 | 16 | 0.4 | 0.06->32 | 95 | 0 | 5 |
Levofloxacin | 1 | 1 | 0.9 | 0.50-1 | 100 | 0 | 0 |
Sutterella wadsworthensis (12) | |||||||
Doripenem | 4 | 8 | 2.3 | 0.06-32 | 73 | 18 | 9 |
Ertapenem | 0.5 | 1 | 0.3 | 0.03-1 | 100 | 0 | 0 |
Imipenem | 1 | 4 | 1.2 | 0.03-16 | 91 | 0 | 9 |
Meropenem | 4 | 4 | 1.1 | 0.03->32 | 92 | 0 | 8 |
Ceftriaxone | >32 | >32 | 3.2 | 0.25->32 | 25 | 0 | 75 |
Levofloxacin | 0.5 | 2 | 0.7 | 0.25-2 | 100 | 0 | 0 |
Clostridium species (25) | |||||||
Doripenem | 1 | 2 | 0.5 | 0.03-4 | 100 | 0 | 0 |
Ertapenem | 2 | 8 | 0.8 | 0.03-8 | 84 | 16 | 0 |
Imipenem | 2 | 8 | 0.9 | 0.03-8 | 80 | 20 | 0 |
Meropenem | 1 | 2 | 0.5 | 0.03-4 | 100 | 0 | 0 |
Ceftriaxone | 8 | 32 | 5.3 | 0.25->32 | 72 | 24 | 4 |
Levofloxacin | 4 | 32 | 4 | 0.25-32 | 28 | 28 | 44 |
Anaerobic gram-positive cocci (18) | |||||||
Doripenem | 0.031 | 0.12 | 0 | 0.03-0.25 | 100 | 0 | 0 |
Ertapenem | 0.031 | 0.25 | 0.1 | 0.03-0.25 | 100 | 0 | 0 |
Imipenem | 0.062 | 0.062 | 0 | 0.03-0.12 | 100 | 0 | 0 |
Meropenem | 0.031 | 0.12 | 0 | 0.03-0.12 | 100 | 0 | 0 |
Ceftriaxone | 0.25 | 4 | 0.4 | 0.12-4 | 100 | 0 | 0 |
Levofloxacin | 0.5 | 2 | 0.5 | 0.25-8 | 95 | 0 | 5 |
Nonsporing gram-positive rods (30) | |||||||
Doripenem | 0.12 | 0.25 | 0.2 | 0.03-8 | 97 | 3 | 0 |
Ertapenem | 0.12 | 0.5 | 0.2 | 0.03-16 | 97 | 0 | 3 |
Imipenem | 0.12 | 0.25 | 0.1 | 0.03-1 | 100 | 0 | 0 |
Meropenem | 0.062 | 0.25 | 0.1 | 0.03-8 | 97 | 3 | 0 |
Ceftriaxone | 0.25 | 0.5 | 0.2 | 0.06-16 | 100 | 0 | 0 |
Levofloxacin | 2 | 8 | 1.7 | 0.25-32 | 80 | 7 | 13 |
Total (364) | |||||||
Doripenem (424) | 0.25 | 1 | 0.3 | 0.03-32 | 98 | 1 | 1 |
Ertapenem | 0.25 | 1 | 0.2 | 0.03->32 | 98 | 1 | 1 |
Imipenem | 0.12 | 1 | 0.2 | 0.03-16 | 98 | 2 | 0 |
Meropenem | 0.12 | 0.5 | 0.2 | 0.03->32 | 99 | 1 | 0 |
Ceftriaxone | 32 | >32 | 3 | 0.03->32 | 47 | 29 | 24 |
Levofloxacin | 1 | 8 | 1.7 | 0.06->32 | 69 | 11 | 20 |
%S, %I, and %R, percentage of isolates susceptible, intermediate, or resistant, respectively; grp., group. Susceptible (intermediate) breakpoints used were as follows: for ertapenem, imipenem, and meropenem, 4 (8) μg/ml; and for ceftriaxone, 16 (32) μg/ml. Doripenem does not have a CLSI-approved breakpoint, and a tentative breakpoint of 4 (8) μg/ml was used to facilitate comparison with the other carbapenems. A tentative breakpoint of 2 (4) μg/ml was used for levofloxacin, which also does not have a CLSI-approved breakpoint.
No. of isolates.
No. of isolates tested with doripenem.